Christopher Mocek, MD
Pain Medicine · Little Rock, ARNPI 1821050618
Payments from drug & device makers
Across 277 payments — averaging $36.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Flowonix Medical Incorporated$949
- Biodelivery Sciences International, Inc.$944
- Relievant Medsystems, Inc.$863
- Nevro Corp.$837
- Si-bone, Inc.$817
- plus $4K from 32 others
What the payments were for
- Speaking & faculty fees$7507%
- Travel & lodging$2,93629%
- Food & beverage$5,61255%
- Entertainment$9499%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $1,607 |
| Flowonix Medical Incorporated | 1 | $949 |
| Biodelivery Sciences International, Inc. | 19 | $944 |
| Relievant Medsystems, Inc. | 7 | $863 |
| Nevro Corp. | 38 | $837 |
| Si-bone, Inc. | 2 | $817 |
| Boston Scientific | 13 | $535 |
| Collegium Pharmaceutical, Inc. | 45 | $530 |
| Stryker | 1 | $497 |
| Vertos Medical, Inc. | 5 | $288 |
| Pfizer | 22 | $255 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $252 |
| SPR Therapeutics, Inc | 4 | $205 |
| Idorsia Pharmaceuticals US Inc | 9 | $192 |
| Saluda Medical Americas, Inc. | 7 | $192 |
| Merck | 10 | $186 |
| Medtronic(2 entities) | 4 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Daiichi Sankyo Inc. | 8 | $121 |
| Curonix LLC | 1 | $98 |
| Averitas Pharma Inc. | 3 | $69 |
| Vertex | 3 | $59 |
| Piramal Critical Care | 4 | $58 |
| Ultragenyx Pharmaceutical Inc. | 3 | $56 |
| Kaleo, Inc. | 3 | $46 |
| Globus Medical | 1 | $37 |
| Eisai Inc. | 3 | $37 |
| Baudax Bio Inc. | 2 | $36 |
| AbbVie | 1 | $28 |
| Redhill Biopharma Inc. | 2 | $24 |
| Amgen | 2 | $24 |
| Nalu Medical, Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Stimwave Technologies Incorporated | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Kinex Medical Company LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$3,002
- PROCLAIM$1,041
- Prometra II$949
- IFUSE IMPLANT SYSTEM$780
- BELBUCA$750
- OPTABLATE$497
- Omnia$275
- Senza$174
- mild Device Kit$146
- QUVIVIQ$123
- Evoke$109
- SYNCHROMEDII$101
- Proclaim Family of SCS IPGs$101
How this compares
$10,247 in reported general payments places this provider in the 80th percentile of 53 pain medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 869 | $27,512 |
| Buprenorphine | 69 | $17,836 |
| Oxycodone Hcl | 1,115 | $16,315 |
| BelsomraSuvorexant | 39 | $16,118 |
| NucyntaTapentadol Hcl | 15 | $15,979 |
| BelbucaBuprenorphine Hcl | 19 | $15,533 |
| Xtampza ErOxycodone Myristate | 41 | $14,382 |
| Fentanyl | 170 | $14,091 |
| Morphine Sulfate ErMorphine Sulfate | 448 | $9,593 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 316 | $8,350 |
| Hydromorphone Hcl | 571 | $7,865 |
| Morphine Sulfate | 232 | $5,611 |
| Hysingla ErHydrocodone Bitartrate | 18 | $5,142 |
| Lubiprostone | 33 | $3,648 |
| Naloxone Hcl | 43 | $2,793 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca, Xtampza Er | $530 | $45,89575 claims |
| MerckBelsomra | $186 | $16,11839 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 53 pain medicine providers in Arkansas.
Other pain medicine in Little Rock
- Stephen PaulusLittle Rock$75K
- Julio OlayaLittle Rock$22K
- Ann IkonneLittle Rock$8K
- Saint AdeogbaLittle Rock$6K
- Andrew CainLittle Rock$5K
- Krishnappa PrasadLittle Rock$5K
- Thomas HartLittle Rock$4K
- James CaldwellLittle Rock$4K
- Terry FletcherLittle Rock$3K
- Drew BeasleyLittle Rock$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.